Steven Belinsky

Dr. Steven Belinsky

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in Nature Reviews Cancer
Verified
Journal Article
Closed access
SBSteven Belinsky
Steven Belinsky

13 April 2011 in Cancer Research
Verified
Journal Article
Open access
PDF file
CTCarmen S. Tellez
Carmen S. Tellez
DJDaniel E. Juri
Daniel E. Juri
KDKieu Do
Kieu Do
ABAmanda M. Bernauer
Amanda M. Bernauer
CTCindy L. Thomas
Cindy L. Thomas
SBSteven Belinsky
Steven Belinsky
Epithelial-to-mesenchymal transition (EMT) is strongly associated with cancer progression, but its potential role during premalignant development has not been studied. Here, we show that a 4-week exposure of immortalized human bronchial epithelial cells (HBEC) to tobacco carcinogens can induce a persistent, irreversible, and multifaceted dedifferentiation program marked by EMT and the emergence of stem cell–like properties. EMT induction was epigenetically driven, initially by chromatin remodeling through H3K27me3 enrichment and later by ensuing DNA methylation to sustain silencing of tumor-suppressive microRNAs (miRNA), miR-200b, miR-200c, and miR-205, which were implicated in the dedifferentiation program in HBECs and also in primary lung tumors. Carcinogen-treated HBECs acquired stem cell–like features characterized by their ability to form spheroids with branching tubules and enrichment of the CD44high/CD24low, CD133, and ALDH1 stem cell–like markers. miRNA overexpression studies indicated that regulation of the EMT, stem-like, and transformed phenotypes in HBECs were distinct events. Our findings extend present concepts of how EMT participates in cancer pathophysiology by showing that EMT induction can participate in cancer initiation to promote the clonal expansion of premalignant lung epithelial cells. Cancer Res; 71(8); 3087–97. ©2011 AACR.

15 September 2005 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SBSteven Belinsky
Steven Belinsky
DKDonna M. Klinge
Donna M. Klinge
JDJoseph D. Dekker
Joseph D. Dekker
MSMitzi W. Smith
Mitzi W. Smith
TBTheresa J. Bocklage
Theresa J. Bocklage
MPMaria A. Picchi
Maria A. Picchi
Purpose: Lung cancer is the leading cause of cancer mortality in the United States, due in part to the lack of a validated and effective screening approach for early detection. The prevalence for methylation of seven and three genes was examined in DNA from sputum and plasma, respectively, from women at different risk for lung cancer.

15 April 2002
Verified
Journal Article
Closed access
SBSteven Belinsky
Steven Belinsky
WPWilliam A Palmisano
William A Palmisano
FGFrank D Gilliland
Frank D Gilliland
LCLida A Crooks
Lida A Crooks
KDKevin K Divine
Kevin K Divine
RCRichard E Crowell
Richard E Crowell

5 January 2013 in Human Genomics
Verified
Journal Article
Open access
PDF file
YLYushi Liu
Yushi Liu
TNToru Nyunoya
Toru Nyunoya
SLShuguang Leng
Shuguang Leng
SBSteven Belinsky
Steven Belinsky
YTYohannes Tesfaigzi
Yohannes Tesfaigzi
SBShannon Bruse
Shannon Bruse
The estimation of genetic ancestry in human populations has important applications in medical genetic studies. Genetic ancestry is used to control for population stratification in genetic association studies, and is used to understand the genetic basis for ethnic differences in disease susceptibility. In this review, we present an overview of genetic ancestry estimation in human disease studies, followed by a review of popular softwares and methods used for this estimation.

20 January 2005 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
SBSteven Belinsky
Steven Belinsky
Transcriptional silencing by CpG island hypermethylation has become a critical component in the initiation and progression of lung cancer. The ability of pharmacologic agents to reverse promoter hypermethylation also makes it an attractive target to pursue for prevention of lung cancer. Animal models, together with studies in humans have fostered significant advances in elucidating the role of gene-specific methylation in cancer initiation and progression, the modulation of promoter methylation by carcinogen exposure and the ability to block tumor development by preventing epigenetically mediated gene silencing. These advances represent the beginning of efforts to develop a progression model for lung cancer that should aid efforts for early detection and gene targeting for therapy, and the development of preventive interventions that reverse epigenetic-mediated gene silencing.